Loading stock data...

Welcome to the Late-Stage Discount Market Where Everything Is On Sale But Few Folks Are Buying

The Exchange

Startups, Markets and Money

Valuation Pressure Mounts for Late-Stage Startups

If you are raising money for an early-stage startup today, there’s reason to be hopeful when it comes to the price that you might be able to charge for shares in your company. However, the later stage your startup is, the worse your chances are to raise funds at a price that you like.

New Data from CB Insights

New data from CB Insights indicates that, on a global basis, the farther along the alphabet a startup’s next funding round is, the more valuation pressure that transaction will be under from a price perspective. This trend is surprising in how clear it is in trend terms, but not too surprising.

The Decline of Mega-Rounds

Recall that mega-rounds, or venture capital deals worth $100 million or more, have fallen precipitously this year. While median deal size through the third quarter has been flat in the early- and mid-stage startup market, late-stage deals have gotten smaller this year.

Why Q3’s Median Valuations Actually Make Perfect Sense

With that backdrop, falling late-stage valuations are hardly surprising. Venture investor and SaaS aficionado Jason Lemkin had this to say today:

"My summary of Venture Markets in Nov 2022: Series B and later even worse than looks in data: 85%+ of investing here has simply ceased[.] Lower volume implies less demand; less demand implies less competition around deal price; less competition means lower prices."

The Pain of Late-Stage Startups

Let’s examine the pain that late-stage startups are dealing with today, and what it could mean for unicorns jammed between changing venture preferences and a seemingly closed IPO market.

The Good and Bad News

Compared to 2021, global seed and angel deals in Q3 2022 are being valued 29% more richly, clocking in at $15.1 million (all per-round data reported on a median basis), according to CB Insights. Series A deals, per the same dataset, are up a more modest 20%.

The Decline of Valuations

However, as we move further along the alphabet, valuations decline sharply:

  • Q3 2022 Series B median valuations are off 11% compared to 2021.
  • Q3 2022 Series C median valuations are off 21% compared to 2021.
  • Q3 2022 Series D+ median valuations are off 31% compared to 2021.

The Hangover Phase

This decline makes sense; last year we saw too many companies raise too much money, too quickly, at too great a price. An explosion in capital from outside normal venture circles played a role in inflating late-stage fundraising and valuations.

What It Means for Unicorns

For unicorns, this trend is particularly concerning. With changing venture preferences and a seemingly closed IPO market, these companies are facing significant challenges in raising funds at the right price.

The Future of Late-Stage Fundraising

As the market continues to evolve, it’s likely that late-stage fundraising will become even more challenging for startups. However, this trend also presents opportunities for innovative companies that can adapt and thrive in a changing environment.

Related Stories

  • OpenAI’s AI reasoning model ‘thinks’ in Chinese sometimes and no one really knows why: Kyle Wiggers
  • UK’s CMA slaps Google Search and its 90%+ market share with an antitrust investigation: Ingrid Lunden
  • Bioptimus raises $41M to develop a ‘GPT for biology’: Paul Sawers

Subscribe to The Exchange

Get the latest news on startups, markets, and money delivered straight to your inbox every week. Subscribe now!

[Insert newsletter signup form]

Follow Us

Twitter: @theexchangeTC
Facebook: @theexchangetc
LinkedIn: @the-exchange-tc